LANE ANDREW H 4
4 · ABBOTT LABORATORIES · Filed Aug 31, 2021
Insider Transaction Report
Form 4
LANE ANDREW H
Senior Vice President
Transactions
- Exercise/Conversion
Common shares without par value
2021-08-27$38.40/sh+135,925$5,219,520→ 222,012 total - Exercise/Conversion
Option (right to buy)
2021-08-27−135,925→ 0 totalExercise: $38.40From: 2019-02-19Exp: 2026-02-18→ Common Shares (135,925 underlying) - Sale
Common shares without par value
2021-08-27$125.47/sh−135,925$17,055,189→ 86,087 total
Holdings
- 1,543(indirect: By Trust)
Common shares without par value
Footnotes (4)
- [F1]Includes shares acquired pursuant to a dividend reinvestment feature.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.96 to $125.72, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Balance in the Abbott Laboratories Stock Retirement Trust as of August 27, 2021.
- [F4]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.